Skip to main content

Jeff Lagasse

By Jeff Lagasse | 01:57 pm | April 20, 2016
Raleigh Orthopaedic Clinic of North Carolina will pay $750,000 to settle charges that it violated the Health Insurance Portability and Accountability Act of 1996 Privacy Rule.
By Jeff Lagasse | 11:30 am | April 20, 2016
New research released by The Maine Heritage Policy Center has found significant variations in costs for certain procedures among Maine hospitals sometimes representing thousands of dollars, or in a handful of cases, five times the amount.
By Jeff Lagasse | 10:07 am | April 19, 2016
Blood testing startup Theranos is under investigation by the U.S. Securities and Exchange Commission and the U.S. Attorney's Office for the Northern District of California.
By Jeff Lagasse | 12:50 pm | April 18, 2016
Third-party nonprofits promising scientific and transparent drug value assessments are gaining ground in healthcare, even as many drug manufacturers are challenging their methodologies, according to new research by the Health Research Institute.
By Jeff Lagasse | 03:46 am | April 18, 2016
By incorporating factors like risk adjustment and utilization rates, organizations can essentially create their own population health box scores, experts say.
By Jeff Lagasse | 11:33 am | April 15, 2016
The new emergency department will include an expansion from 20 beds to 26, and the department's physical space will more than double.
By Jeff Lagasse | 02:13 pm | April 14, 2016
If finalized, the affiliation would create an organization with 181 locations in Florida, Illinois, Indiana, Kentucky and Tennessee, employing more than 4,500 people and serving an estimated 150,000 patients.
By Jeff Lagasse | 03:37 pm | April 13, 2016
Laboratory's receipt of Medicare payments also in question.
By Jeff Lagasse | 01:34 pm | April 13, 2016
Staff learned in a company-wide letter that they would not be paid until this Friday.
By Jeff Lagasse | 11:02 am | April 13, 2016
A collaboration between scientists, clinicians and industry partners, the institute will spearhead efforts in cancer immunotherapy research -- benefitting from what amounts to the largest single contribution ever made to the field.